Trip secures £10m for mainstream CBD push

Product Focus

CBD start-up Trip has secured a £10m investment to fuel its rapid growth and bring the brand to a mainstream customer base.

Already have an account? Sign in here

Want access to this article?

Register for LIMITED access

REGISTER FOR FREE

Get PREMIUM access for £1 a week

SUBSCRIBE NOW